Santen Pharmaceutical Co., Ltd. (TYO:4536)
Japan
· Delayed Price · Currency is JPY 1,551.00
-5.50 (-0.35%)
At close: Dec 5, 2025
Santen Pharmaceutical Revenue
Santen Pharmaceutical had revenue of 69.14B JPY in the quarter ending September 30, 2025, a decrease of -3.48%. This brings the company's revenue in the last twelve months to 291.48B, down -3.66% year-over-year. In the fiscal year ending March 31, 2025, Santen Pharmaceutical had annual revenue of 300.00B, down -0.65%.
Revenue (ttm)
291.48B
Revenue Growth
-3.66%
P/S Ratio
1.71
Revenue / Employee
75.73M
Employees
3,849
Market Cap
498.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 300.00B | -1.96B | -0.65% |
| Mar 31, 2024 | 301.97B | 22.93B | 8.22% |
| Mar 31, 2023 | 279.04B | 12.78B | 4.80% |
| Mar 31, 2022 | 266.26B | 16.65B | 6.67% |
| Mar 31, 2021 | 249.61B | 8.05B | 3.33% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,213.71B |
| HOYA Corporation | 892.50B |
| Takeda Pharmaceutical Company | 4,417.00B |
| Daiichi Sankyo Company | 1,978.88B |
| Otsuka Holdings | 2,418.53B |
| Astellas Pharma | 2,006.82B |
| Terumo | 1,062.42B |
| Shionogi & | 437.26B |
Santen Pharmaceutical News
- 4 weeks ago - Santen Pharmaceutical reports Q2 results - Seeking Alpha
- 7 months ago - Santen Pharmaceutical Co., Ltd. reports Q4 results - Seeking Alpha
- 3 years ago - Santen Pharmaceutical Co., Ltd. (SNPHY) Management on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha